Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

WASHINGTON--(BUSINESS WIRE)--ACAMS, the global partner to the AML, fraud and sanctions communities, published its annual Global Anti-Financial Crime Threats Report identifying the top financial crime threats for the coming year. The report is based on a survey of 1,400 global AFC professionals across more than 200 jurisdictions. The report shows convergence of technology, geopolitics and criminal innovation is creating new threats of unprecedented scale and complexity. These threats are outpaci...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, in a larger vial size, 375mg/75mL, for adult and pediatric patients with T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma (T-LBL). Nelarabine Injection carries a Boxed Warning. Please see Important Safety Information below and full Pres...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved an NDA labeling supplement allowing for re-administration of iDose® TR using a repeat treatment protocol. The FDA approval is in response to Glaukos’ 2025 NDA labeling supplement application, and re...

NEW YORK--(BUSINESS WIRE)--Melio, a leading accounts payable and receivable platform, announced today the launch of “Agent Mel,” an AI-powered assistant and expert guide that delivers quick responses and valuable insight for payment, product, and vendor questions. The conversational agent helps accountants, bookkeepers, and SMBs access critical information and gain understanding to make faster, smarter decisions. As B2B sectors rapidly adopt AI, Agent Mel addresses the growing demand for intell...

LONDON--(BUSINESS WIRE)--Sokin, the global business payments company, has secured a $100 million long-term debt facility from Oxford Finance LLC (“Oxford”), a leading specialty lender. The facility will accelerate Sokin's expansion across North America, Asia, the Middle East, and South America, and fast-track the acquisition of further regional licenses, banking partnerships, and global infrastructure scaling. Additionally, investments will fund the development and launch of new products, inclu...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that Aeva management will participate in the following investor event: Oppenheimer 11th Annual Emerging Growth Conference Location: Virtual Date: February 3, 2026 Institutional investors can contact their sales representative at Oppenheimer to register and request a meeting. About Aeva Technologies, Inc. (Nasdaq: AEVA) Aeva’s mission is to bring the next wave...

NEW YORK--(BUSINESS WIRE)--BlinkRx, the leading digital health company transforming access to prescription medications, today announced that former Congressman Cedric Richmond (D-LA) has joined BlinkRx as a Senior Advisor. Richmond brings decades of experience at the highest levels of public service, policy development, and strategic leadership. During his six terms in the U.S. House of Representatives, he served on the powerful House Ways and Means, Judiciary, and Homeland Security Committees,...

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for AI-powered clinical development, today launched Agentic AI for research sites to reduce burden and assist principal investigators (PIs) in oversight and monitoring of electronic clinical outcome assessment (eCOA) data. Medable’s newest agent integrates seamlessly within its eCOA system workflows. Released just after Medable’s TMF and CRA agents, its PI Summary Agent continues the company’s rapid rollout of fun...

NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (the “Company”, “Bowhead Specialty”) (NYSE: BOW) announced today that it will release financial results for the fourth quarter of 2025 at approximately 7:00 a.m. Eastern Time before the market opens on Tuesday, February 24, 2026. The earnings documents will be available on the Company’s Investor Relations website at https://ir.bowheadspecialty.com. The Company will host a conference call to discuss its results on the same day, Tuesday,...